| Literature DB >> 16369248 |
Abstract
Venlafaxine is a widely used serotonin- and norepinephrine-reuptake inhibitor-type antidepressant that causes serious adverse effects in at least 5% of cases. Serious withdrawal symptoms may occur within hours of cessation or reduction of the usual dosage and may affect motor and coordination skills to such a degree that patients should be explicitly urged either to adhere to a strict medication routine or not to drive a car. Recent clinical evidence about withdrawal symptoms is presented that may indicate incidents in noradrenergic activity irrespective of dosage.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16369248 PMCID: PMC1681629
Source DB: PubMed Journal: MedGenMed ISSN: 1531-0132